tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Apollo Medical Holdings (AMEH) and Twist Bioscience (TWST)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBVResearch Report), Apollo Medical Holdings (AMEHResearch Report) and Twist Bioscience (TWSTResearch Report).

AbbVie (ABBV)

Barclays analyst Carter Gould maintained a Hold rating on AbbVie on August 5 and set a price target of $160.00. The company’s shares closed last Friday at $138.04.

According to TipRanks.com, Gould is a 3-star analyst with an average return of 4.3% and a 48.6% success rate. Gould covers the Healthcare sector, focusing on stocks such as Travere Therapeutics, Merck & Company, and Eli Lilly & Co.

Currently, the analyst consensus on AbbVie is a Moderate Buy with an average price target of $159.38, which is a 14.6% upside from current levels. In a report issued on August 1, Atlantic Equities also downgraded the stock to Hold with a $162.00 price target.

See the top stocks recommended by analysts >>

Apollo Medical Holdings (AMEH)

Barclays analyst Sarah James maintained a Hold rating on Apollo Medical Holdings on August 5 and set a price target of $57.00. The company’s shares closed last Friday at $54.40.

According to TipRanks.com, James is a 5-star analyst with an average return of 13.1% and a 68.3% success rate. James covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Acadia Healthcare, and Oak Street Health.

Apollo Medical Holdings has an analyst consensus of Hold, with a price target consensus of $57.00.

Twist Bioscience (TWST)

Barclays analyst Luke Sergott maintained a Buy rating on Twist Bioscience on August 5 and set a price target of $55.00. The company’s shares closed last Friday at $52.77.

According to TipRanks.com, Sergott is a 4-star analyst with an average return of 6.6% and a 48.1% success rate. Sergott covers the Healthcare sector, focusing on stocks such as IQVIA Holdings, Thermo Fisher, and Sotera Health.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Twist Bioscience with a $55.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ABBV:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More